Prime Editing: A Novel Cas9-Reverse Transcriptase Fusion May Revolutionize Genome Editing.
Human gene therapy, 30(12): 1445-1446 PMID 31860398 DOI 10.1089/hum.2019.29098.trf
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.